Alterity Therapeutics
ATHE
12 hedge funds and large institutions have $834K invested in Alterity Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
100% more capital invested
Capital invested by funds: $416K → $834K (+$418K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
8% less funds holding
Funds holding: 13 → 12 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$379K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$48.3K |
| 3 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$21.5K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.69K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$498 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.68K |
| 2 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$53 |
| 3 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
-$18 |
ATHE Hedge Fund Activity: Q1 2025 in Review
12 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q1 2025, worth a combined $834K — up 100% from $416K a quarter earlier.
Fund positioning in ATHE was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 1 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $379K. The largest seller was Morgan Stanley, cutting an estimated $2.68K.
- 12 institutional investors held Alterity Therapeutics (ATHE) as of Q1 2025, down from 13 in Q4 2024.
- Funds reported $834K of Alterity Therapeutics stock for Q1 2025, up 100% quarter-over-quarter.
- 2 funds opened new Alterity Therapeutics positions in Q1 2025 and 2 closed out, a net change of 0 holders.
- The largest Alterity Therapeutics buyer in Q1 2025 was Point72 Asset Management, an estimated $379K added.
- The largest Alterity Therapeutics seller in Q1 2025 was Morgan Stanley, an estimated $2.68K sold.
Based on aggregated 13F filings for Q1 2025.